Sunday, January 15, 2023 8:45:55 PM
THE STOCK IS TREMENDOUSLY UNDERVALUED AT .0055S.
Market Cap Market Cap
$1,976,469.ITS HOULD BE 4 TIMES THE YEARLY REVENUE=AROUND $22 MILLION CAP.OR .061 PPS.
https://www.otcmarkets.com/otcapi/company/financial-report/356971/content
1)Revenue $ 1,156,862
2)Net Comprehensive Profit $ 71,015
3)Cash and cash equivalents at the
beginning of the year $ 469,987
Cash and cash equivalents at the
4) end of the period $ 529,046
5)Total Shareholders' Equity $ 1,549,888 FROM $ 1,478,873
6)Total Liabilities $ 482,127 FROM $ 546,347
7)ZERO DILUTION FOR THE LAST TWO YEARS.NUMBERS BELOW.
As of November 30, 2022, the number of shares outstanding of our Common Stock was:
359,357,992
As of August 31, 2022 the number of shares outstanding of our Common Stock was:
359,357,992
As of August 31, 2021, the number of shares outstanding of our Common Stock was:
359,357,992
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM